Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing injection plus ambroxol for pulmonary infection in elderly patients with heart failure
ChiCTR1900022879Phase 4Not yet recruiting
- Sponsor
- Sanya People's Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tanreqing and ambroxol in heart failure (HF) and pulmonary infection (2 arms), sponsored by Sanya People's Hospital. Primary endpoint: Total effective rate. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
tanreqingambroxol
03
Conditions
heart failure (HF)pulmonary infection
Beyond the preview
Go deeper on ChiCTR1900022879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022879.